2010-11-04 00:00:00,Stanley Chesley Files Class Action Against Johnson Johnson And DePuy
2010-11-10 00:00:00,Johnson Unit Janssen Pharmaceutica Together with Eight Other Companies to Collaborate on Data Share on Psychiatric
2010-11-19 00:00:00,Takeda Pharmaceutical Company Limited and Johnson Johnson Recall Batches of Cancer Drug
2010-11-23 00:00:00,Johnson Johnson Recalls 4 Million Packages Of
2010-11-24 00:00:00,Johnson Johnson Recalls More Cites Label
2010-11-29 00:00:00,Tribunal Finds Johnson Johnson In Breach Of License Agreement With Basilea Pharmaceutica AG
2010-12-01 00:00:00,Johnson Janssen Pharmaceutica Announces Collaboration to Develop Diagnostic Biosignatures for Identification of Disease
2010-12-06 00:00:00,Lawsuits Against Johnson Johnson Involving Defective DePuy Hip Replacement Parts To Be consolidated In Multidistrict Litigation
2010-12-08 00:00:00,Jury Rules Against Johnson Johnson In Antibiotic
2010-12-13 00:00:00,DePuy Hip Replacement Class Action Commenced by Stevensons LLP Against Johnson Johnson
2010-12-23 00:00:00,Johnson Janssen Announces New Drug Submission For Abiraterone Acetate For The Treatment Of Metastatic Advanced Prostate Cancer
2010-12-28 00:00:00,FDA Places Johnson Johnson Pain Drug On Clinical
2011-01-05 00:00:00,Bayer Johnson Johnson Ask For Approval For Main Use Of
2011-01-25 00:00:00,Johnson Johnson Issues FY 2011 EPS Guidance Below Estimates
2011-01-28 00:00:00,Johnson Johnson Receives Approval from European Commission For Acquisition Of Crucell
2011-01-31 00:00:00,Johnson Johnson Announces Recall of DePuy Hip Lewitt Hackman Files Suit
2011-02-16 00:00:00,Johnson Johnson Recalls Invega
2011-02-17 00:00:00,Johnson Johnson And Crucell Announce Minimum Acceptance Condition Satisfied
2011-02-18 00:00:00,Johnson Johnson Recalls Two Lots Of Simponi Injection
2011-02-22 00:00:00,Johnson Johnson Completes Tender Offer For Crucell And Declares Offer Unconditional
2011-02-24 00:00:00,Abbott Boston Scientific Boston Scientific Ceska Johnson Medtronic Czechia and Others Win Daily News
2011-03-08 00:00:00,Johnson Johnson Acquires Of Issued Crucell Shares
2011-03-09 00:00:00,Johnson Johnson Recalls Leaky Insulin
2011-03-11 00:00:00,FDA To Oversee Johnson Johnson Plants After Flood Of
2011-03-14 00:00:00,Eli Lilly and Elanco Announces Offer To Acquire Janssen Pharmaceutica Janssen Animal Health Business
2011-03-23 00:00:00,POZEN Announces Licensing Deal with Johnson Cilag GmbH for MT Migraine Treatment
2011-03-24 00:00:00,Johnson Johnson Unit Recalls Surgical Drain
2011-03-29 00:00:00,Johnson Johnson Issues More Drug
2011-03-31 00:00:00,Johnson Johnson Reorganizes Consumer Group In Wake Of
2011-04-05 00:00:00,Higher Bleeding Risk Seen In Johnson Johnson And Bayer AG Clot
2011-04-08 00:00:00,Johnson Johnson Announces Settlement With Department Of Justice And Securities and Exchange Commission
2011-04-14 00:00:00,Johnson Johnson Recalls Bottles Of Epilepsy
2011-04-15 00:00:00,Johnson Johnson Provides Additional Information Regarding Amended Agreement With Merck
2011-04-18 00:00:00,Synthes Confirms In Deal Talks With Johnson
2011-04-19 00:00:00,Johnson Johnson Raises FY 2011 EPS Guidance
2011-04-27 00:00:00,Johnson Johnson To Acquire Inc
2011-04-28 00:00:00,Johnson Johnson Announces Dividend Increase Of
2011-04-29 00:00:00,Johnson Centocor Ortho Biotech Products LP Informs to Zeltia Pharma Mar SA Its Decision to Withdraw the NDA for Yondelis in Combination With Doxil
2011-05-20 00:00:00,US FDA Approves New Johnson Johnson HIV
2011-05-23 00:00:00,Johnson Johnson Acquires Russian OTC Medicines For
2011-05-24 00:00:00,JB Chemicals Pharmaceuticals Limited To Sell Business And Worldwide Rights And Registrations Of Three OTC Brands To Johnson Cilag GmbH International
2011-05-26 00:00:00,Johnson Johnson To Seek Approval For 11 New Drugs By
2011-06-01 00:00:00,Johnson Terminates Agreement with Diamyd Medical AB Concerning Diabetes Therapy
2011-06-02 00:00:00,Korres Appoints New Chief Executive Announces Initiation Of Business Deal With Johnson Johnson
2011-06-14 00:00:00,Johnson Johnson Wins Approval For Hip Replacement
2011-06-15 00:00:00,Johnson Johnson To Quit Struggling Heart Stent
2011-06-16 00:00:00,Johnson Johnson To Exit Stent To CLose Two Announces
2011-06-24 00:00:00,US FDA urges caution on And Johnson Johnson Anemia
2011-06-28 00:00:00,Gilead And Johnson Tibotec Unit To Develop Combination HIV
2011-07-01 00:00:00,US Regulators Approve Bayer AG And Johnson Blood
2011-07-07 00:00:00,Johnson Johnson Announces Global Sponsorship Of 2014 FIFA World Cup Brazil
2011-07-18 00:00:00,Johnson Johnson Announces Third Quarter 2011 Quarterly Dividend
2011-07-19 00:00:00,FDA Panel To Consider Additional Use For Johnson Remicade In Pediatric
2011-08-10 00:00:00,Johnson Johnson Reaches Agreement In Principle With The Justice Department To Plead Guilty To A Misdemeanor Violation Of A Federal
2011-08-26 00:00:00,Johnson Janssen Pharmaceuticals Inc Unit Gets FDA Approval For Pain Drug Nucynta
2011-09-06 00:00:00,Bayer AG And Johnson Johnson Stroke Drug Not Ready For Approval From US
2011-09-08 00:00:00,Johnson Johnson Announces FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban For Prevention Of Stroke Systemic Embolism In Patients With Non Valvular Atrial Fibrillation
2011-09-14 00:00:00,Johnson Johnson Pleads Guilty In Natrecor Marketing
2011-09-23 00:00:00,Bayer AG And Johnson Xarelto Recommended for Approval in the Prevention of AF Related Stroke and Treatment of Deep Vein Thrombosis in EU
2011-09-28 00:00:00,Boston Scientific Did Not Infringe Johnson Unit US Court Upholds Blood Vessel Stent
2011-09-29 00:00:00,Boston Scientific Announces Favorable Appellate Court Ruling Affirming of Johnson Johnson Patent
2011-10-13 00:00:00,Johnson Johnson Starts Trading on OTC
2011-10-18 00:00:00,Johnson Johnson Raises Low End Of Prior FY 2011 EPS Guidance To A Range In Line With Estimates
2011-10-21 00:00:00,Johnson Johnson Announces Fourth Quarter 2011 Quarterly Dividend
2011-11-09 00:00:00,Affymax Inc and Johnson Janssen Biotech Settles Patent Dispute
2011-11-17 00:00:00,Johnson Johnson To Nix Baby Product Contaminant Within Two
2011-12-02 00:00:00,Squibb And Johnson Johnson Team Up Against Hepatitis
2011-12-08 00:00:00,Johnson Janssen Initiates Phase II Clinical Trial with CNTO 1959 with MorhoSys AG
2011-12-12 00:00:00,Symmetry Medical To Acquire Surgical Instruments Business of Codman Shurtleff A Johnson Johnson Company
2012-01-03 00:00:00,Johnson Johnson Announces 2012 Quarterly Dividend
2012-01-12 00:00:00,Johnson Biosense Webster Announces FDA Approval Of THERMOCOOL SF Catheter In The United States
2012-01-18 00:00:00,FDA Warns Johnson DePuy Unit Over Joint
2012-01-20 00:00:00,Johnson Johnson To Pay Million To Settle Texas Risperdal
2012-01-23 00:00:00,Federal Court Rules In Favor Of Boston Scientific in Johnson Johnson
2012-01-24 00:00:00,Johnson Johnson Issues FY 2012 EPS Guidance Below Estimates
2012-02-08 00:00:00,FDA Says Ulcer Drugs Such As AstraZeneca Nexium May Raise Diarrhea Other Proton Pump Inhibitors Includes Johnson Johnson and Eisai Co
2012-02-21 00:00:00,Alex Gorsky To Succeed Bill Weldon As CEO Of Johnson Johnson
2012-03-15 00:00:00,Johnson Johnson Set To Win EU Okay To Buy Synthes
2012-03-26 00:00:00,Johnson Janssen Research LLC Announces XARELTO Demonstrates Comparable Efficacy To Standard of Care For Treatment Secondary Prevention Of Venous Blood Clots
2012-04-11 00:00:00,Johnson Johnson Hit With Billion Risperdal Penalty In
2012-04-17 00:00:00,Johnson Johnson Raises FY 2012 EPS Guidance
2012-04-19 00:00:00,EU Clears Johnson Billion Acquisition Of Synthes
2012-04-26 00:00:00,Johnson Johnson Announces Dividend Increase Of
2012-05-16 00:00:00,Johnson Johnson Shows Promise In High Risk Prostate
2012-05-24 00:00:00,US Advisers Reject Johnson Xarelto For Acute Coronary
2012-06-05 00:00:00,Law Office of Brodsky LLC Investigates Potential Claims Against Johnson DePuy Orthopedics
2012-06-13 00:00:00,Johnson Johnson Expects To Complete Billion Purchase Of Synthes on
2012-06-14 00:00:00,Johnson Johnson Announces Completion of Synthes Inc Acquisition
2012-06-20 00:00:00,Johnson Johnson Close To Settling With DOJ Over
2012-06-21 00:00:00,US FDA Rejects Wider Use For Johnson And Bayer
2012-07-09 00:00:00,Bayer AG And Johnson Xarelto Gets FDA Priority
2012-07-16 00:00:00,Johnson Johnson Announces Quarterly Dividend For Third Quarter 2012
2012-07-17 00:00:00,Johnson Johnson Lowers FY 2012 EPS Guidance
2012-07-24 00:00:00,Pfizer Johnson Johnson Drug Fails One Of Four Big Reuters
2012-08-21 00:00:00,Johnson Unit Recalls Bone
2012-08-30 00:00:00,Johnson Janssen Announces Global License And Development Agreement For Investigational Agent Daratumumab With Genmab
2012-09-04 00:00:00,Johnson Johnson Announces Indirect Stake in Galapagos NV
2012-09-13 00:00:00,Johnson Johnson Picks Bayer Bayer CropScience AG Executive Sandra Peterson As Group Worldwide
2012-10-04 00:00:00,Johnson Johnson Agrees to Settle Five Rispersal Suits
2012-10-09 00:00:00,Johnson Johnson Goldman Street Whispers
2012-10-15 00:00:00,Earnings Johnson Johnson Analyst Blog
2012-10-16 00:00:00,Genmab Announces Results of Private Placement to Johnson Johnson Development Corporation
2012-10-17 00:00:00,Johnson Johnson Announces Quarterly Dividend For Fourth Quarter 2012
2012-10-18 00:00:00,Johnson Johnson A Stock For Dividend Investors No Capital
2012-10-22 00:00:00,Johnson High Dividend Strong Capital Position
2012-10-23 00:00:00,Johnson Litigation Makes This Pharma A Pass In 2013
2012-10-25 00:00:00,Johnson Johnson to Host Medical Devices Diagnostics Review
2012-10-26 00:00:00,The Zacks Analyst Blog Johnson Chesapeake
2012-10-31 00:00:00,Johnson Johnson Given Rating at Zacks
2012-11-01 00:00:00,Johnson Johnson Is En Route To
